(Q42574234)

2 November 2017

Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (English)

1 reference

lymphoproliferative disorders

2 November 2017

0 references

1 reference

6

A J Demetris

1 reference

2 November 2017

9

T E Starzl

1 reference

2 November 2017

7

J J Fung

1 reference

2 November 2017

2

A Zeevi

1 reference

2 November 2017

M A Nalesnik

1

1 reference

2 November 2017

P S Randhawa

3

1 reference

2 November 2017

A Faro

4

1 reference

2 November 2017

K J Spichty

5

1 reference

2 November 2017

T L Whiteside

8

1 reference

2 November 2017

1 February 1999

1 reference

2 November 2017

Clinical Transplantation

1 reference

2 November 2017

13

1 reference

2 November 2017

1 Pt 1

1 reference

2 November 2017

39-44

1 reference

In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Epstein-Barr virus strategy in normal and neoplastic B cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3022484

The rapid development of a fatal, disseminated B cell lymphoma following liver transplantation--serial changes in levels of soluble serum interleukin 2 and interleukin 4 (B cell growth factor)

16 August 2018

1 reference

12 December 2020

Interleukin-10 in human heart transplantation: an in situ hybridization study. The Manchester Transplant Cytokine Group

1 reference

12 December 2020

Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop

1 reference

12 December 2020

Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines

1 reference

12 December 2020

Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine

1 reference

12 December 2020

Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation

1 reference

12 December 2020

10.1034/J.1399-0012.1999.T01-2-130106.X

Identifiers

DOI

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

10081633

1 reference